Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.


BACKGROUND A randomized phase II trial was conducted to determine if two non-platinum protocols are able to yield a similar efficacy and toxicity profile as compared to two platinum-based doublets in advanced non-small cell lung cancer (NSCLC). PATIENTS AND METHODS A total of 61 patients were randomly assigned to a reference regimen of carboplatin and… (More)


  • Presentations referencing similar topics